Estonian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
sarcoidosis/rasvumus
Link salvestatakse lõikelauale
Leht 1 alates 48 tulemused
[Sarcoidosis and obesity].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
Polypliagia and morbid obesity appears in patients with sarcodosis may be signs of neurosarcoidosis in the medial hypothalmus where satiety center is located. It is estimated that about 1% of all patients with sarcoidosis may have sarcoidosis of the hxpothalamus. It is of utmost
Hypothalamic sarcoidosis: a new cause of morbid obesity.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
I have described a 21-year-old man who had biopsy-proven hypothalamic sarcoidosis and polyphagia with a weight increase to 393 lb (178.6 kg) on a 5 ft 4 inch frame during a seven-year follow-up. This morbid obesity appears to be due to sarcoid invasion of the satiety center in the ventral medial
Obesity and sarcoidosis: consequence or contributor?
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
OBJECTIVE
Sarcoidosis is a multisystem disease of unknown cause. Obesity can affect many physiological factors. The relationship between obesity and sarcoidosis is unclear, and can been described as posing a 'chicken and egg' scenario for the patient as it is not always clear whether it is a
Smoking, obesity and risk of sarcoidosis: A population-based nested case-control study.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Smoking and obesity might alter the risk of sarcoidosis. However, the data remained inconclusive.
A cohort of Olmsted County, Minnesota residents diagnosed with sarcoidosis between January 1, 1976 and December 31, 2013 was identified based on individual medical record review. For each sarcoidosis
Glucocorticoid Treatment of Symptomatic Sarcoidosis in 2 Morbidly Obese Patients.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Corticosteroid management for patients with sarcoidosis requires the need for close monitoring to detect and manage any complications that may arise during treatment.
Sarcoidosis and obesity: twin problems for the patient.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
[Preliminary results of the use of a new derivative of rifamycin SV in the treatment of sarcoidosis].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Seven patients with advanced forms of mediastino-pulmonary sarcoidosis (involvement of the pulmonary parenchyma, and restrictive respiratory syndrome), confirmed by histopathologic investigation, have been treated with a new SV-rifamycin derivative, 1246-EH, or "Reprimum" without any other
Considerations regarding sarcoidosis in the bariatric surgical patient.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
The sarcoidosis patient who seeks surgical management for obesity presents many challenges. The interaction between sarcoidosis and obesity complicates both disorders and creates special issues to consider when contemplating surgery. This manuscript will review the approach to pre- and postoperative
Sarcoidosis mimicking a venous ulcer: a case report.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Sarcoidosis--a chronic, multisystem disease of unknown etiology characterized by noncaseating granulomas--may cause ulcerative lesions, particularly in African American women. A case of ulcerative sarcoidosis mimicking a venous ulcer is presented. The patient is a 44-year-old African American
The challenges of extrapulmonary presentations of sarcoidosis: A case report and review of diagnostic strategies.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
A patient presenting with overweight, amenorrhea, diabetes insipidus, and oral, nasal, and pharyngeal inflammation was admitted to our hospital. Using a non-invasive approach, we were able to narrow the differential diagnosis down to a systemic lymphoproliferative or granulomatous disease, most
Evaluation of the efficacy and toxicity of the cyclosporine A-flucortolone-methotrexate combination in the treatment of sarcoidosis.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Eleven patients with chronic sarcoidosis resistant to high-dose corticosteroids and other immunosuppressive treatments were treated with cyclosporine A at the initial daily dose of 5 mg per kg body weight (ideal weight in the case of overweight subjects) combined with flucortolone and methotrexate.
Body composition profiling in a Dutch sarcoidosis population.
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
Muscle atrophy is a common problem in many chronic inflammatory diseases. It may occur as part of a generalized wasting process (cachexia) or be hidden due to preservation of fatmass (sarcopenia, sarcopenic obesity).
OBJECTIVE
The aim of this study was to assess the prevalence of cachexia and muscle
[Sarcoidosis localized in endocrine glands].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
BACKGROUND
There is a relationship between sarcoidosis and endocrine diseases: hypothalamus, hypophysis, thyroid gland, parathyroid gland, adrenal gland and calcium metabolism disorder.
CONCLUSIONS
Neurological disorders, obesity, secondary hypogonadism, and thirst as a result of diabetes insipidus,
[The advantages of Reprimum therapy in pulmonary sarcoidosis and other granulomatous diseases].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
In sarcoidosis and other granulomatous non-caseous diseases, the election treatment is immunosuppressive, mainly with cortisones that ensure more than 70% lasting remissions. Continuous use of cortisones for a long time (8-30 months) in high doses leads to serious side effects: gastric and
[Extensive interactions between eating and weight disorder, major depression, pain, and sarcoidosis - case 5/2012].
Ainult registreeritud kasutajad saavad artikleid tõlkida
Logi sisse
METHODS
We report on a 41-year-old female patient suffering from obesity, binge eating more than twice a week with loss of control, eating rapidly and feeling guilty after eating, dyspnoea and chronic pain in the whole body, especially in her arms, legs and in both ankles. Furthermore, subdued mood,
Kõige täiuslikum ravimtaimede andmebaas, mida toetab teadus
- Töötab 55 keeles
- Taimsed ravimid, mida toetab teadus
- Maitsetaimede äratundmine pildi järgi
- Interaktiivne GPS-kaart - märgistage ürdid asukohas (varsti)
- Lugege oma otsinguga seotud teaduspublikatsioone
- Otsige ravimtaimi nende mõju järgi
- Korraldage oma huvisid ja hoidke end kursis uudisteuuringute, kliiniliste uuringute ja patentidega
Sisestage sümptom või haigus ja lugege ravimtaimede kohta, mis võivad aidata, tippige ürdi ja vaadake haigusi ja sümptomeid, mille vastu seda kasutatakse.
* Kogu teave põhineb avaldatud teaduslikel uuringutel
